Review
Copyright ©The Author(s) 2022.
World J Gastroenterol. Oct 21, 2022; 28(39): 5679-5690
Published online Oct 21, 2022. doi: 10.3748/wjg.v28.i39.5679
Figure 1
Figure 1 Different therapeutic approaches used to inhibit the consequences of the receptor of advanced glycation end-products axis activation in cancer. RAGE: Receptor of advanced glycation end-products; AGEs: Advanced glycation end-products.